Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01690052 · ClinicalTrials.gov registry record · NA
Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva
A NA study, sponsored by University of Kentucky.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01690052 is a NA study that has completed, run by University of Kentucky. The registered enrollment target is 15 participants.
The verdict
NCT01690052, a NA study, has completed, sponsored by University of Kentucky.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
The main objectives were: 1) To determine the efficacy of both cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia, and 2) To compare the side-effects between the treatment for xerostomia with cevimeline and with pilocarpine.
Interventions
- DRUG Pilocarpine
- DRUG Cevimeline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01690052
The ClinicalTrials.gov registry entry for NCT01690052 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Kentucky, which has 54 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pilocarpine is the first listed.
NCT01690052 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01690052 about?
NCT01690052 is a clinical study titled "Efficacy of Cevimeline Versus Pilocarpine in the Secretion of Saliva". The main objectives were: 1) To determine the efficacy of both cevimeline and pilocarpine in the secretion of saliva in patients with xerostomia, and 2) To compare the side-effects between the treatment for xerostomia with cevimeline and with pilocarpine.
What is the current status of trial NCT01690052?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2009-01. Estimated completion is 2010-07.
What interventions are being tested in trial NCT01690052?
The interventions under investigation include: Pilocarpine (DRUG), Cevimeline (DRUG).
Who is sponsoring clinical trial NCT01690052?
This trial is sponsored by University of Kentucky, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.